Ra Medical Systems (NYSE:RMED) this week announced the realignment of its board of directors in conjunction with the recently announced merger with Catheter Precision.
David Jenkins joins the board as executive chair, and James Caruso will serve as a director. Martin Colombatto, Will McGuire and Susann Meline will serve as directors. Additionally, directors Joan Stafslien and Richard Mejia have resigned.
Ra Medical’s board of directors membership will remain at five.
The company also made several adjustments to the board, including:
- Meline has been named lead independent director and chair of the governance/nomination committee. She will also serve on the audit committee.
- Colombatto will continue as chair of the compensation committee and remain on the governance/nomination committee.
- Caruso was named chair of the Audi committee and will serve on the compensation committee.
“We are pleased to make these adjustments to our board, including the appointment of James Caruso, who brings significant financial background, making him ideal for chair of our audit committee. Our new board is fully committed to advising and governing Ra Medical for future growth with a primary focus in the cardiac electrophysiology marketplace. We thank our former board members for their service,” Jenkins said in a news release.
Ra Medical Systems announced on January 10 that it completed its merger with Catheter Precision. Under the terms of the agreement, Catheter Precision became a wholly-owned subsidiary of Ra Medical.
